BioAge Labs, Inc. (BIOA)
10.11
+0.73
(+7.78%)
USD |
NASDAQ |
Aug 25, 16:00
10.19
+0.08
(+0.79%)
Pre-Market: 08:42
BioAge Labs EPS Diluted (Quarterly) : -0.582 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.582 |
| March 31, 2026 | -0.5238 |
| December 31, 2025 | -0.7185 |
| September 30, 2025 | -0.5626 |
| June 30, 2025 | -0.6015 |
| March 31, 2025 | -0.3606 |
| December 31, 2024 | -0.5894 |
| Date | Value |
|---|---|
| September 30, 2024 | -0.6845 |
| June 30, 2024 | -0.3975 |
| March 31, 2024 | -0.3802 |
| December 31, 2023 | -0.6129 |
| September 30, 2023 | -0.4277 |
| June 30, 2023 | -0.503 |
| March 31, 2023 | -0.3244 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.939 |
| Pfizer Inc. | -0.0435 |
| Oramed Pharmaceuticals, Inc. | 1.839 |
| Liquidia Corp. | 0.7369 |
| Neumora Therapeutics, Inc. | -0.2327 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.10M |
| Revenue (Quarterly) | 2.451M |
| Total Expenses (Quarterly) | 28.55M |
| Enterprise Value | 146.89M |
| Gross Profit Margin (Quarterly) | 97.14% |
| Profit Margin (Quarterly) | -1.06K% |
| Earnings Yield | -23.61% |
| Normalized Earnings Yield | -23.51 |